Literature DB >> 21508638

Integrated cytogenetic and high-resolution array CGH analysis of genomic alterations associated with MYCN amplification.

A Pandita1, J Bayani, J Paderova, P Marrano, C Graham, M Barrett, M Prasad, M Zielenska, J A Squire.   

Abstract

Amplification of oncogenes and closely linked flanking genes is common in some types of cancer and can be associated with complex chromosome rearrangements and/or co-amplification of non-syntenic chromosomal regions. To better understand the etiology and structural complexity of focal MYCN amplicons in human neuronal cancer, we investigated the precise chromosomal locations of high copy number genomic regions in MYCN amplified cell lines. An integrated cytogenetic map of the MYCN amplicon was created using high-resolution array CGH, spectral karyotyping (SKY), multi-color banding (mBAND), and fluorescence in situ hybridization (FISH) in 4 human neuronal tumor cell lines. The evidence of complex intra- and inter-chromosomal events, providing clues concerning the nature of the genomic mechanisms that contributed to the process of MYCN amplification, was observed. The presence of multiple co-amplified syntenic or non-syntenic sequences in the MYCN amplicon is quite intriguing. MYCN is usually centrally located in the amplicon; however, the structure and complexity of the amplicons were highly variable. It is noteworthy that clusters of unstable repetitive regions characterized by CNV sequences were present throughout the regions encompassed by MYCN gene amplification, and these sequences could provide a mechanism to destabilize this region of the genome. Complex structural rearrangements involving genomic losses and gains in the 2p24 region lead to MYCN amplification and that these rearrangements can trigger amplification events.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508638     DOI: 10.1159/000324698

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  2 in total

1.  Single nCounter assay for prediction of MYCN amplification and molecular classification of medulloblastomas: a multicentric study.

Authors:  Daniel Antunes Moreno; Luciane Sussuchi da Silva; Maicon Fernando Zanon; Murilo Bonatelli; Flávia Escremim de Paula; Marcus de Medeiros Matsushita; Gustavo Ramos Teixeira; Iara Viana Vidigal Santana; Fabiano Saggioro; Luciano Neder; João N Stavale; Suzana Maria Fleury Malheiros; Matheus Lima; Glaucia Noeli Maroso Hajj; Hernan Garcia-Rivello; Silvia Christiansen; Susana Nunes; Maria João Gil da Costa; Maria José Soares; Jorge Pinheiro; Carlos Almeida Junior; Bruna Minniti Mançano; Rui Manuel Reis
Journal:  J Neurooncol       Date:  2022-02-15       Impact factor: 4.130

2.  Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell death.

Authors:  Christopher J Del Nagro; Jonathan Choi; Yang Xiao; Linda Rangell; Sankar Mohan; Ajay Pandita; Jiping Zha; Peter K Jackson; Thomas O'Brien
Journal:  Cell Cycle       Date:  2013-02-01       Impact factor: 4.534

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.